SCHEMBL7188845

SCHEMBL7188845

O=C(O)C(=O)CC(=O)c1ccn(Cc2ccc(F)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
ERCC5 P28715 5/20 0.43
FEN1 P39748 5/20 0.43
PTPN1 P18031 4/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HAO1 Q9UJM8 3/20 0.41
KDM4A O75164 1/20 0.41
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CYP19A1 P11511 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
CNR2 P34972 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196180 0.87 FEN1 (0.59) ERCC5FEN1PTPN1NPC1RAB9A
SCHEMBL7184197 0.87 FEN1 (0.54) ERCC5FEN1PTPN1HAO1CA12
SCHEMBL7183825 0.86 HAO1 (0.54) ERCC5FEN1PTPN1HAO1CYP19A1
SCHEMBL7191520 0.86 ERCC5 (0.43) POLBERCC5FEN1PTPN1NPC1
SCHEMBL7188216 0.85 PTPN1 (0.41) POLBERCC5FEN1PTPN1HAO1
SCHEMBL7191241 0.84 HAO1 (0.47) POLBERCC5FEN1PTPN1NPC1
SCHEMBL7189635 0.83 ERCC5 (0.50) ERCC5FEN1CYP19A1KMT2A
SCHEMBL7191674 0.83 HAO1 (0.60) ERCC5FEN1PTPN1NPC1RAB9A
SCHEMBL7191455 0.79 FEN1 (0.58) ERCC5FEN1PTPN1NPC1HAO1
SCHEMBL4675445 0.78 NPC1 (0.47) POLBNPC1RAB9AKDM4AKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP claimed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US claimed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP claimed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO claimed
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP disclosed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US disclosed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP disclosed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed